Health News Briefs: Key Developments in U.S. Policies, Pharma Industry, and Technological Innovations

Current health news highlights include misleading claims about measles vaccines, Neuralink's $8.5 billion valuation move, and efforts to phase out synthetic food dyes. Notable stories also cover trade tensions affecting drug prices and Abbott's financial outlook amidst market challenges.

A recent KFF poll reveals that many Americans have encountered misleading claims concerning measles and its vaccines, leading to confusion and uncertainty.

In tech developments, Elon Musk's Neuralink seeks a substantial valuation, aiming to expand its pioneering endeavours in brain implant technology.

Meanwhile, U.S. health authorities plan to eliminate synthetic food dyes, citing potential health risks, as pharma industries push for regulatory clarity amidst a fluctuating market landscape.

(With inputs from agencies.)